5 Things You Can Expect for Gilead Sciences With Its New CEO at the Helm

5 Things You Can Expect for Gilead Sciences With Its New CEO at the Helm

Submitted by admin on May 5, 2019 - 10:34am
Source: 
Motley Fool
News Tags: 
Gilead Sciences
Daniel O'Day
M&A
Kite Pharma
filgotinib
Headline: 
5 Things You Can Expect for Gilead Sciences With Its New CEO at the Helm
snippet: 

It's a new day at Gilead Sciences (NASDAQ: GILD). You might even say that it's a new O'Day. Former Roche Pharmaceuticals CEO Daniel O'Day joined Gilead in March as its new top executive. 

Do Not Allow Advertisers to Use My Personal information